Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
In-depth Analysis of Drug Discovery Informatics Market Industry Landscape
The global drug discovery informatics market is set to reach US$ 7.8 BN by 2032, at a 10 .8% CAGR between years 2023 - 2032. The drug discovery informatics market is notable for rapid technological progress. Drugs are more and more being discovered through continuous progress in bioinformatics, cheminformatics, and computational tools.
Mixing artificial intelligence (AI) and machine learning algorithms greatly improves data analysis, helping to unearth more effective new drug candidates. This complexity of biological data has a major impact on market forces. Drug discovery informatics solves the problem of dealing with immense data sets originating from genomics, proteomics, and other omics technologies.
Organizing, analysing, and interpreting complex biological information is a key function of advanced informatics platforms. Informed decision making on drugs depends heavily upon such activity. Now, personalized medicine is changing the shape of drug discovery. One of the functions of drug discovery informatics is to analyse patient-specific data, thereby leading us to determine molecular targets and develop strategies for personalized treatment.
The drive towards precision medicine is spurring the development and implementation of informatics solutions for pharmaceutical R & D organizations. Drug discovery informatics market dynamics are driven by collaboration. Strategic collaborations pharmaceutical companies may work with informatics service providers, academic institutions, and technology firms to bring in specialized skills, strengthening their own information capabilities as a result. These alliances speed up drug discovery.
The massive data produced in drug discovery calls for strong informatics solutions that can process, analyse, and make sense out of the volumes. The emergence of big data analytics tools designed especially for drug discovery applications is helping to overcome difficulties in storing, processing, and making sense out of the oodles of information generated. This has an impact on market dynamics.
A clear trend in drug discovery is the integration of various omics technologies including genomics, proteomics, and metabolomics. Informatics platforms that can integrated and comprehensively analyse multi-omics data enhance the understanding of diseased pathology and drug response. As pharmaceutical data is so sensitive, the degree of data security and adherence to regulatory standards have a significant impact on market dynamics.
Value proposition There is considerable interest among pharmaceutical companies in solutions for drug discovery informatics which offer robust security and compliance with data protection regulations. This affects purchasing decisions, and ultimately market share. The drug discovery informatics market periodically undergoes consolidation through mergers and acquisitions.
| Report Attribute/Metric | Details |
|---|---|
| Segment Outlook | Product, Mode, Service, and RegionGeographies CoveredNorth America, Europe, Asia Pacific, and the Rest of the WorldCountries CoveredThe US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and BrazilKey Companies Profiled Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Certara, L.P., Infosys Limited, Novo Informatics Pvt. Ltd., Collaborative Drug Discovery Inc., Selvita, Charles River Laboratories, Inc., International Business Machines Corporation, Jubilant Life Sciences Ltd., IO Informatics, Inc., GVK Biosciences Private Limited, and Dassault SystèmesKey Market OpportunitiesProduct releases and R&D by significant critical playersKey Market DynamicsGrowing emphasis on medication discoveryThere is a growing need to control medication discovery and development expenses.Increase in R&D spendingThe chronic illness burden is growing. |
Drug Discovery Informatics Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
